Published in Cancer Weekly, July 27th, 1998
"Our results suggest that the whole molecular structure of KN-208 is required for inhibition," A. Ogawa and colleagues from Nagoya University wrote ("Sulfated Glycoglycerolipid From Archaebacterium Inhibits Eukaryotic DNA Polymerase Alpha, Beta, and Retroviral Reverse Transcriptase and Affects Methyl Methanesulfonate Cytotoxicity," International Journal of Cancer, May 18, 1998;76(4):512-518).
A sulfated glycoglycerolipid, 1-0-(6'-sulfo-alpha-D-glucopyranosyl)-2,3-di-O-phy tanyl- sn-glycerol (KN-208), a derivative of the polar lipid...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.